Are you a new member? Sign up now
Login area
| Sign up
close
CETROTIDE - 0.25mg - 1 x 1ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H01CC02 | B | Cetrorelix (acetate) - 0.25mg | 11312 | 107821 | CETROTIDE | 0.25mg | 1 x 1ml | Injectable lyophilised powder for solution+diluent | SC | Food & Drug Corporation FDC | Fareva Pau 2 | France | 3,420,079 L.L | 23.08 | B | Merck Europe BV | The Netherlands | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H01CC02 | B | Cetrorelix (acetate) - 0.25mg | 521 | 405528 | CETROTIDE | 0.25mg | 1 x 1ml | Injectable lyophilised powder for solution+diluent | SC | Food & Drug Corporation FDC | Baxter Oncology GmbH | Germany | 3,420,079 L.L | 23.08 | B | 2/5/2024 | 0 | ||
| H01CC02 | B | Cetrorelix (acetate) - 0.25mg | 522 | 405527 | CETROTIDE | 0.25mg | 7 x 1ml | Injectable lyophilised powder for solution+diluent | SC | Food & Drug Corporation FDC | Baxter Oncology GmbH | Germany | 21,354,452 L.L | 19.35 | D | 2/5/2024 | 0 | ||
| H01CC02 | B | Cetrorelix (acetate) - 0.25mg | 11311 | 41122 | CETROTIDE | 0.25mg | 7 x 1ml | Injectable lyophilised powder for solution+diluent | SC | Food & Drug Corporation FDC | Fareva Pau 2 | France | 21,354,452 L.L | 19.35 | D | Merck Europe BV | The Netherlands | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024